article thumbnail

6 challenges healthtech can help us tackle – Pt.2

Digital Health Global

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. DiMasi, H.G.

article thumbnail

Teladoc Livongo merger: what went wrong with the 'one-stop shop for virtual care' strategy?

Lloyd Price

These devices collect data about the user's health, which is then sent to Livongo's platform. Mobile apps: Livongo has a mobile app that allows users to track their health data, set goals, and receive coaching from Livongo's team of experts. 2016: Livongo launches its diabetes management platform.

article thumbnail

The outlook for healthcare in 2022

Waracle

London health tech startups secured a staggering $2.9 billion in funding, and the fastest-growing subsector in London is remote monitoring and wearables, raising $345 million in 2021, which is 20 times more than what it was in 2016. . In fact, Exscientia stands by the claim that all drugs in the future will be made using AI. .